US 7208501
Quinuclidine carbamate derivatives and their use as M3 antagonists
granted A61PA61P1/00A61P1/04
Quick answer
US patent 7208501 (Quinuclidine carbamate derivatives and their use as M3 antagonists) held by Almirall Prodesfarma S.A. expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Almirall Prodesfarma S.A.
- Grant date
- Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/06, A61P11/00